What are the next steps for liposomal chemotherapy delivery and CPX-351?
Understanding the mechanisms of venetoclax and ibrutinib resistance
What does the CLL forum data tell us?
Comparing continuous and fixed duration myeloma treatment with triplets and doublets
Ibrutinib combination therapy in CLL: overview of the data so far